CN Patent

CN111333633B — 一种瑞卢戈利的中间体化合物及其制备方法和用途

Assigned to Jiangxi Kerui Pharmaceutical Co ltd · Expires 2023-10-20 · 3y expired

What this patent protects

本发明公开了瑞卢戈利全新的中间体化合物及其制备方法，其中间体化合物纯度高，可用于制备瑞卢戈利及其盐、其衍生物或其类似物；本发明还公开了瑞卢戈利的制备方法，所得成品收率高、纯度高，且未检出缩脲副产物。

USPTO Abstract

本发明公开了瑞卢戈利全新的中间体化合物及其制备方法，其中间体化合物纯度高，可用于制备瑞卢戈利及其盐、其衍生物或其类似物；本发明还公开了瑞卢戈利的制备方法，所得成品收率高、纯度高，且未检出缩脲副产物。

Drugs covered by this patent

Patent Metadata

Patent number
CN111333633B
Jurisdiction
CN
Classification
—
Expires
2023-10-20
Drug substance claim
No
Drug product claim
No
Assignee
Jiangxi Kerui Pharmaceutical Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.